NasdaqGM - Delayed Quote USD

89bio, Inc. (ETNB)

7.70
-0.08
(-0.96%)
At close: 4:00:01 PM EDT
7.70
0.00
(0.00%)
After hours: 4:20:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
403,288
384,656
151,204
102,249
89,743
Operating Income
-403,288
-384,656
-151,204
-102,249
-89,743
Net Non Operating Interest Income Expense
17,347
18,269
12,882
242
-526
Other Income Expense
--
--
--
--
-526
Pretax Income
-385,941
-366,387
-138,322
-102,007
-90,269
Tax Provision
732
692
3,867
19
-147
Net Income Common Stockholders
-386,673
-367,079
-142,189
-102,026
-90,122
Diluted NI Available to Com Stockholders
-386,673
-367,079
-142,189
-102,026
-90,122
Basic EPS
-3.46
--
-2.00
-2.93
-4.48
Diluted EPS
-3.46
--
-2.00
-2.93
-4.48
Basic Average Shares
117,344.21
--
71,172.87
34,806.35
20,098.34
Diluted Average Shares
117,344.21
--
71,172.87
34,806.35
20,098.34
Total Operating Income as Reported
-403,288
-384,656
-151,204
-102,249
-89,743
Total Expenses
403,288
384,656
151,204
102,249
89,743
Net Income from Continuing & Discontinued Operation
-386,673
-367,079
-142,189
-102,026
-90,122
Normalized Income
-386,673
-367,079
-142,189
-102,026
-90,122
Interest Income
23,041
23,559
17,676
2,164
148
Interest Expense
5,694
5,290
4,794
1,922
674
Net Interest Income
17,347
18,269
12,882
242
-526
EBIT
-380,247
-361,097
-133,528
-100,085
-89,595
EBITDA
-380,208
-361,059
-133,478
-100,020
-89,516
Reconciled Depreciation
39
38
50
65
79
Net Income from Continuing Operation Net Minority Interest
-386,673
-367,079
-142,189
-102,026
-90,122
Normalized EBITDA
-380,208
-361,059
-133,478
-100,020
-89,516
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/11/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AKRO Akero Therapeutics, Inc.
38.14
-1.88%
 
JANX Janux Therapeutics, Inc.
24.17
-0.45%
 
CYTK Cytokinetics, Incorporated
30.75
-0.81%
 
DAWN Day One Biopharmaceuticals, Inc.
6.48
+3.68%
 
ITOS iTeos Therapeutics, Inc.
8.41
+7.68%
 
SRRK Scholar Rock Holding Corporation
30.16
-1.28%
 
MDGL Madrigal Pharmaceuticals, Inc.
290.72
-0.08%
 
ACLX Arcellx, Inc.
58.51
-0.46%
 
BBIO BridgeBio Pharma, Inc.
33.69
-0.44%
 
EWTX Edgewise Therapeutics, Inc.
14.79
+0.07%